ZNF521 and plasma cell myeloma: A property of ZNF521 potentially relevant to cancer was discovered by La Rocca et al. [91] who showed that enforced expression of ZNF521 enhances HLA Class I expression on the tumour cell surface, with particular regard to multiple myeloma cells, thereby preventing their recognition by natural killer cells.